Yoshiki Sawa, M.D., Ph.D.
It is my great honor to serve as the Congress Chairperson for the 82nd Annual Scientific Meeting of the Japanese Circulation Society (JCS), which will be held at the Osaka International Convention Center, RIHGA Royal Hotel Osaka and Dojima River Forum, on March 23 (Fri.)-25 (Sun.), 2018. Regarding the Department of Surgery at Osaka University, Dr. Hisao Manabe, an Emeritus Professor of the First Department of Surgery, was appointed as chairperson for the 47th Annual Scientific Meeting, and Dr. Yasunaru Kawashima, an Emeritus Professor, for the 60th Annual Scientific Meeting. Therefore, I will be the third person from the university to receive such an honor. All staff of the Division of Cardiovascular Surgery, Department of Surgery, Osaka University are extremely proud to sponsor this long-established scientific meeting in Osaka. I would like to extend my heart-felt gratitude to all members for granting us such a great opportunity.
We have chosen, as the main theme of this meeting, “Futurability -Pioneering the Future of Circulatory Medicine-” The word, futurability, consisting of “future” and “ability,” is a neologism, which stands for the ability of the future, created and registered as a trademark by Osaka University Hospital. Recently, many experts, who develop and practice multimodality therapy, including catheter treatment and surgical treatment as well as pharmacologic treatment for circulatory diseases, have begun to gather and engage in discussion at JCS, and have achieved extraordinary results and contribution to society. We can see, on the one hand, the world trends, medical environments, medical services, and medical economics undergoing rapid changes and deterioration. In order to overcome catastrophic illnesses in this field, legislation for circulatory diseases is advancing. The time has come for the solicitation of next-generation circulatory medicine. Now we must contemplate what should constitute the essence of cardiovascular medicine, how it should develop toward the future, as medicine for the future generation, and how its ability should be displayed. During this meeting, in order to open the door to new cardiovascular medicine, we would like to discuss co-creation between internal medicine and surgical pediatrics, next-generation team medicine, how to nurture next-generation human resources, as well as the latest information and knowledge of cardiovascular medicine. Maintaining the concept of fusion development with futuristic technologies, which is a concept very different from that of conventional cardiovascular medicine, we have decided to propose “Futurability”, which means the future ability of cardiovascular medicine, as the main theme of the meeting. In this scientific meeting, we would like you to focus on the “future ability of cardiovascular medicine,” publish and engage in lively discussion of your research results with the suggestion that unprecedented values can be created in the future from these promising new science and technologies.
Dr. Alain Cribier, the founder of TAVI, has been invited as a Mikamo Lecturer and he will talk about TAVI, which has been undergoing rapid development recently.
The Mashimo Memorial Lecture will be given by Dr. Shinya Yamanaka, who invented iPS cells and received the Nobel Prize in Physiology or Medicine. He will talk about the present status and the future of iPS cells. Regarding symposiums and panel discussions, we plan to establish some sessions, through which to publish new messages and discussions to our members and society. As for special events, we will arrange many items related to the latest topics of recent medical practice and experimental medicine in the cardiovascular field. We will also single out important issues concerning the systems and education of young doctors, including new specialist systems and young doctors’ sessions, discuss the framework of cardiovascular medicine, and explore the future ability of cardiovascular medicine, hand in hand with members of the society. We will also try to the best of our ability to select some topics that are common to both surgery and internal medicine. In order to obtain the participation of as many doctors of cardiovascular surgery as possible, we are preparing various special events for cardiovascular surgery, including the wet labo by Dr. Tiron E. David. We are concentrating our efforts on making this meeting completely different from conventional cardiovascular surgery meetings and past meetings of the Japanese Circulation Society
As a symbol character of this meeting, we have adopted Black Jack, a comic character by the manga artist, Mr. Osamu Tezuka, who is a former graduate of Osaka University. We will also exhibit many medicine-related items, based upon the novels by Mr. Ryotaro Shiba, who is another former graduate of Osaka University, and of whom I am a great fan. I hope you will find these events intriguing and entertaining. Gourmet cuisine, unique to Osaka, also awaits you. All the staff of the Division of Cardiovascular Surgery, Department of Surgery, Osaka University, united in one body, will continue to exert their best possible efforts to make this meeting successful. I humbly ask for your generous support.